Very recently, two other newly developed DHODH inhibitors for AML and one for chronic myeloid leukemia (CML) have been described [39–41] (Fig. 2; Table 1). The gene discussed is DHODH; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.